 |
Fc- and CDR-modified humanised monoclonal antibody against C5 |
|---|---|
| Trade Name | |
| Orphan Indication | Paroxysmal nocturnal hemoglobinuria |
| EU Market Approval | EU |
| EU Designation Date | 2016-05-30 00:00:00 |
| Sponsor | Alexion Europe SAS |
| |
Fc- and CDR-modified humanised monoclonal antibody against C5 |
|---|---|
| Trade Name | |
| Orphan Indication | Paroxysmal nocturnal hemoglobinuria |
| EU Market Approval | EU |
| EU Designation Date | 2016-05-30 00:00:00 |
| Sponsor | Alexion Europe SAS |